Beam Therapeutics Inc. - COMMON STOCK (BEAM)

Historical Holders from Q1 2020 to Q4 2025

Symbol
BEAM on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
101,224,395
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
106,522,701
Holdings value
$2,585,111,564
% of all portfolios
0%
Number of holders
210
Number of buys
111
Number of sells
89
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Beam Therapeutics Inc. - COMMON STOCK (BEAM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 14% -9.3% $334,113,385 -$31,963,105 13,766,518 -8.7% FMR LLC 30 Sep 2025
ARK Investment Management LLC 10% +30% $189,880,899 +$70,753,653 10,410,137 +59% ARK Investment Management LLC 31 Jul 2025
Farallon Capital Partners, L.P. 10% +0.9% $154,282,001 +$26,822,768 9,972,980 +21% Dapice Joshua J. 31 Mar 2025
BlackRock, Inc. 7.5% $116,023,917 7,499,930 BlackRock, Inc. 31 Mar 2025
ARCH Venture Fund IX, L.P. 4.6% -17% $71,173,556 4,600,747 0% Robert Nelsen 31 Mar 2025
As of 30 Sep 2025 Beam Therapeutics Inc. - COMMON STOCK (BEAM) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 106,522,701 shares of the company stock as of 30 Sep 2025.

Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 586 $16,244 +$9,009 $27.72 1
2025 Q3 106,522,701 $2,585,111,564 -$9,743,408 $24.27 210
2025 Q2 108,375,993 $1,844,441,951 +$102,159,920 $17.01 214
2025 Q1 101,329,623 $1,984,124,290 +$387,248,263 $19.53 234
2024 Q4 81,428,236 $2,019,868,554 +$53,366,577 $24.80 228
2024 Q3 78,910,409 $1,933,384,478 +$31,923,308 $24.50 217
2024 Q2 77,506,241 $1,816,090,286 +$144,591,864 $23.43 210
2024 Q1 70,038,223 $2,313,329,177 +$41,840,899 $33.04 220
2023 Q4 64,112 $1,793,086 -$751,923 $27.22 3
2023 Q3 67,114,631 $1,614,060,514 +$71,755,106 $24.05 187
2023 Q2 63,867,113 $2,038,971,110 +$114,804,149 $31.93 188
2023 Q1 60,345,320 $1,847,330,018 +$134,972,566 $30.62 202
2022 Q4 55,793,635 $2,182,097,254 +$43,300,035 $39.11 202
2022 Q3 54,383,061 $2,589,986,835 -$481,953 $47.64 208
2022 Q2 54,501,122 $2,075,068,153 +$184,378,466 $38.71 185
2022 Q1 49,155,540 $2,816,588,002 +$203,701,393 $57.30 225
2021 Q4 45,539,373 $3,629,046,128 -$39,014,453 $79.69 222
2021 Q3 45,161,299 $3,932,558,016 -$59,505,878 $87.01 226
2021 Q2 45,449,115 $5,849,969,531 +$329,980,929 $128.71 225
2021 Q1 42,797,684 $3,419,530,423 +$467,392,707 $80.04 203
2020 Q4 36,902,998 $3,012,973,616 +$631,480,173 $81.64 150
2020 Q3 29,515,785 $726,694,347 +$39,373,601 $24.62 80
2020 Q2 27,707,853 $775,554,484 +$33,850,636 $28.00 70
2020 Q1 26,888,544 $483,990,454 +$483,989,851 $18.00 60